Maravai Lifesciences Holdings (MRVI) Restructuring Costs (2023 - 2026)

Maravai Lifesciences Holdings' Restructuring Costs history runs 4 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• In Q1 2026, Restructuring Costs changed N/A year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $20.7 million (up 1035350.0% YoY), while the FY2025 annual figure was $17.8 million, up 1568.45% from the prior year.
• Restructuring Costs for Q1 2026 stood at $2.9 million, down from $10.4 million in the prior quarter.
• The five-year high for Restructuring Costs was $10.4 million in Q4 2025, with the low at -$1.2 million in Q1 2024.
• The 4-year median for Restructuring Costs is $1.4 million (2024), against an average of $3.2 million.
• The sharpest annual moves came in 2024 and 2025: Restructuring Costs tumbled 99.91% in 2024, then jumped 184750.0% in 2025.
• Maravai Lifesciences Holdings' Restructuring Costs stood at $6.5 million in 2023, then sank by 99.91% to $6000.0 in 2024, then soared by 173916.67% to $10.4 million in 2025, then tumbled by 72.44% to $2.9 million in 2026.
• Business Quant data shows MRVI's Restructuring Costs at $2.9 million in Q1 2026, $10.4 million in Q4 2025, and $7.4 million in Q3 2025.